Professor Alan Rowan | Professor Alan E. Rowan’s Post

Di: Ava

Advisory board Team Professor Xiwang Zhang UQ Dow Centre Director & Professor and ARC Future Fellow School of Chemical Engineering Project members Lead Investigator Professor Alan Rowan Executive Institute Director, Australian Institute for Bioengineering and Nanotechnology Senior Group Leader Single-use plastics, such as those used for filtration, are a significant contributor to the plastic waste problem. Plant-derived nanofibres have many advantages, such as being natural, abundant, biodegradable, and are exceptionally light and strong. These nanofibres are excellent candidates for use as sustainable materials to reduce the use of petroleum-based plastics in

Alan Rowan, DrPH - Public Health

Event host and AIBN Institute Director Professor Alan Rowan said a biology-based economy was important to Queensland’s future. “With the success of mRNA vaccines to address COVID-19, we see that vaccines, biologics and cell therapies are the future of medicine and we must continue to invest in the technologies,” Professor Rowan Associate Professor Evan Moore Professor Avril Robertson Dr Benjamin Ross Professor Alan Rowan Professor Gary Schenk Dr Philip Sharpe Dr Paul Shaw

Professor Peter Fratzl Associate Professor Sarah Heilshorn Professor Melissa Little Professor Alan Rowan Dr Anna Waterhouse Winthrop Professor Fiona Wood Program The Australian Research Council today announced Professor Alan Rowan, Director of the AIBN, as an Australian Laureate Fellow. This prestigious award comes just three months after Professor Rowan took up the post as director of the institute, and will support his goal to establish a world-class research initiative centred on the Professor Alan Rowan Affiliate of Centre for Extracellular Vesicle Nanomedicine Centre for Extracellular Vesicle Nanomedicine Faculty of Health, Medicine and Behavioural Sciences Executive Institute Director, Australian Institute for Bioengineering and Nanotechnology Office of

The AIBN in two minutes: Who are we?

“We’ve got things here which are nowhere else on the planet,” says AIBN’s director, Professor Alan Rowan, who took the helm in 2016. Even more remarkable is that these unique facilities Search to find faculties, schools, centres, administrative & service divisions

The institute’s second director, Professor Alan Rowan, commenced in 2016. The AIBN is an integrated multi-disciplinary research institute bringing together researchers in the areas of bioengineering and nanotechnology.

Group Leaders Professor Alan Rowan Executive Institute Director Australian Institute for Bioengineering and Nanotechnology Senior Group Leader IMB Group Leader, Professor John Fraser joins Dr Iris Depaz, Professor Alan Rowan and Professor Avril Robertson in conversation about how biotechnology is transforming the world of medicine. UQ acknowledges the Traditional Owners and their custodianship of the lands on which UQ is situated. — Reconciliation at UQ

Personalised cancer vaccines to be produced at new mRNA lab
Programming Synthetic Dendritic Cells
Queensland shines on the world stage at BioAsia 2025
SerpenSeal, next generation wound management

Bio Professor Alan Rowan became Director of the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland in 2016. Professor Rowan has PhD and first-class honours in chemistry from the University of Liverpool and joined the University of Nijmegen in the Netherlands, where he became a professor, established a new group in

Professor Alan E. Rowan’s Post

Project members Lead Investigator Professor Alan Rowan Executive Institute Director Australian Institute for Bioengineering and Nanotechnology Senior I am excited to continue my tenure on the Australian Research Council College of Experts panel with fellow AIBN leaders and professors Yusuke and Kris. It's always a pleasure being at the Other UQ researchers involved in the various stages of the project include Professor Darren Martin, Dr Nasim Amiralian and Dr Pratheep Kumar Annamalai, who were the original inventors of the underpinning patent family, as well as Professor Alan Rowan.

FSU experts available to reflect on the past year with COVID-19

„[Discovery] often begins with a strange result, an observation which can’t be explained.“ The first genuine biomaterial developed by Prof Alan Rowan FAA in

All of which position the AIBN perfectly to enable the future. When it comes to precision nanomedicine, advanced biomanufacturing and nanoengineered

Professor Alan Rowan FAA, Director of the AIBN and Professor of Chemistry at the University of Queensland. Image supplied by AIBN Copying nature to control cells Rowan’s research bridges the interface between nanotechnology, biology and supramolecular chemistry, which examines the forces between molecules. Single-use plastics, such as those used for filtration, are a significant contributor to the plastic waste problem. Plant-derived nanofibres have many advantages, such as being natural, abundant, biodegradable, and are exceptionally light and strong. These nanofibres are excellent candidates for use as sustainable materials to reduce the use of petroleum-based plastics in

Professor Alan Rowan Affiliate of Centre for Extracellular Vesicle Nanomedicine Centre for Extracellular Vesicle Nanomedicine Faculty of Health, Medicine and Behavioural Sciences Executive Institute Director, Australian Institute for Bioengineering and Nanotechnology Office of Professor Alan Rowan Director, Australian Institute for Bioengineering and Nanotechnology The University of Queensland The Queensland delegation was led by AIBN’s Professor Alan Rowan and included leading Queensland industry and research institutes to showcase the state’s expertise in biotechnology.

Other UQ researchers involved in the various stages of the project include Professor Darren Martin, Dr Nasim Amiralian and Dr Pratheep Kumar Annamalai who were the original inventors of the underpinning patent family, as well as Professor Alan Rowan. Spinifex team members Research team Professor Alan Rowan Executive Institute Director Australian Institute for Bioengineering and Nanotechnology Senior Group Leader

AIBN director Professor Alan Rowan said the hub would complement Australia’s existing research strengths in oncology and affirm AIBN as a therapeutics and personalised medicine pipeline. “Governments and society want sustainable innovation that enables high quality research and delivers translatable outcomes,” Professor Rowan said. Rowan Group Professor Alan Rowan Executive Institute Director Australian Institute for Bioengineering and Nanotechnology Senior Group Leader Sie habe eine höhere Energiedichte, ermögliche also eine längere Nutzungsdauer, und lasse sich 70 Mal schneller aufladen als eine Lithium-Ionen-Batterie, sagt Professor Alan Rowan, Direktor des

The Australian Academy of Science has elected AIBN Director Professor Alan Rowan as a Fellow for his sustained contribution to research and scientific endeavour. All of which position the AIBN perfectly to enable the future. When it comes to precision medicine, advanced biomanufacturing and nanoengineered materials, if you dream it, we can do it. Professor Alan Rowan Director, Australian Institute for Bioengineering and Nanotechnology Professor Alan Rowan Affiliate of Centre for Extracellular Vesicle Nanomedicine Centre for Extracellular Vesicle Nanomedicine Faculty of Health, Medicine and Behavioural Sciences Executive Institute Director, Australian Institute for Bioengineering and Nanotechnology Office of

QQCWB

GV